Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
8(27%)
Results Posted
50%(6 trials)
Terminated
1(3%)

Phase Distribution

Ph not_applicable
15
50%
Ph phase_2
3
10%
Ph phase_1
2
7%
Ph early_phase_1
1
3%
Ph phase_4
2
7%
Ph phase_3
5
17%

Phase Distribution

3

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
1(3.6%)
Phase 1Safety & dosage
2(7.1%)
Phase 2Efficacy & side effects
3(10.7%)
Phase 3Large-scale testing
5(17.9%)
Phase 4Post-market surveillance
2(7.1%)
N/ANon-phased studies
15(53.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

12 of 15 finished

Non-Completion Rate

20.0%

3 ended early

Currently Active

8

trials recruiting

Total Trials

30

all time

Status Distribution
Active(12)
Completed(12)
Terminated(3)
Other(3)

Detailed Status

Completed12
Recruiting5
Not yet recruiting4
Active, not recruiting3
unknown3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
30
Active
8
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.6%)
Phase 12 (7.1%)
Phase 23 (10.7%)
Phase 35 (17.9%)
Phase 42 (7.1%)
N/A15 (53.6%)

Trials by Status

recruiting517%
active_not_recruiting310%
withdrawn27%
completed1240%
terminated13%
not_yet_recruiting413%
unknown310%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT06834633Not Applicable

Nephroprotection in Severe Trauma Patients With Kidney Stress

Recruiting
NCT07638332Phase 1

Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation

Not Yet Recruiting
NCT05672836Phase 4

ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Recruiting
NCT05704829Phase 2

NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer

Recruiting
NCT06192771Not Applicable

Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically

Recruiting
NCT05792332Not Applicable

Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

Active Not Recruiting
NCT02932410Phase 3

A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

Completed
NCT05316701Phase 3

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Active Not Recruiting
NCT05894954Phase 3

Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

Completed
NCT05410548Not Applicable

Comorbidity Screening and Referral by Prosthetists

Completed
NCT07117968Not Applicable

Benefit of Connected Care for Cochlear Implant Management

Not Yet Recruiting
NCT06715605Phase 2

A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS

Withdrawn
NCT06997172Not Applicable

Short- to Medium-term Outcome of Minimally Invasive Carpal Tunnel Release

Not Yet Recruiting
NCT03906136Phase 3

AScalate: Treat-to-target in Axial Spondyloarthritis

Completed
NCT06163742Not Applicable

Novel Donor Site Dressing (Product X)

Not Yet Recruiting
NCT06400927Not Applicable

Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure

Recruiting
NCT05273957Not Applicable

A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism.

Active Not Recruiting
NCT06246604Not Applicable

Screening for Deep Vein Thrombosis in Intensive Care

Unknown
NCT03723005

A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns

Completed
NCT02367690Phase 1

Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients

Withdrawn

Drug Details

Intervention Type
OTHER
Total Trials
30